Modified polymers for delivery of polynucleotides, method of manufacture, and methods of use thereof
AssigneeMersana Therapeutics, Inc.
InventorsAleksandr Yurkovetskiy, Mao Yin, Timothy B. Lowinger, Carolina B. Cabral, Charles E. Hammond, Cheri A. Stevenson
Life of this patent
Estimating the term…
Abstract
A polynucleotide delivery vehicle comprising a modified polymer is provided herein, the modified polymer having the following formula: in which W1, W2, W3, W4, W5, W6, Z1, Z2, Z3, Z4, Z5, Z9, R1, R2, R3, R4, R5, n1, n2, n3, n4, n5, and n6 are defined herein. Also disclosed are methods of delivering a polynucleotide to the cytoplasm of a selected tissue type or cell type and methods of reducing expression of a gene in a cell or a subject in need thereof with the modified polymer.
Claims31
A modified polyacetal of Formula (VI):
- wherein:
- each of W1, W2, W3, W4, W5 and W6, independently, is a covalent bond or —C(O)—Y— with —C(O) connected to the polyacetal backbone;
- Y is —[C(R9R10)]a— or —[C(R9R10)]a—X1—[C(R9R10)]b—;
- X1 is an oxygen atom, a sulfur atom or —NR11;
- each of R9 and R10 independently is hydrogen, C1-6 alkyl, C6-10 aryl, 5 to 12-membered heteroaryl or C3-8 cycloalkyl;
- R11 is hydrogen, C1-6 alkyl, C6-10 aryl, 5 to 12-membered heteroaryl, C3-8 cycloalkyl or —C(O)—C1-3 alkyl;
- Z9 is Z6-T1 or Z8;
- T1 is —Z7—R6;
- Z8 is a linear or branched polyamino moiety substituted with one or more —Z7—R6 and optionally substituted with one or more substituents selected from the group consisting of -Q-R1, -Q-R3, -Q-R4, and -Q-R5;
- each Q independently is a covalent bond or —C(O)—;
- each of Z1, Z2, Z3, Z4, Z5, and Z6, independently, is a covalent bond, —NR17, or —NR17R18—, in which each of R17 and R18 independently is H, C2-8 alkyl, or —C2-10 alkyl-N(Rx)—, Rx being H or an amino acid attached to the nitrogen via the carbonyl group of the amino acid;
- or R17 and R18, together with the nitrogen atom to which they are attached form a 4 to 7-membered heterocycloalkyl ring containing 0 or 1 additional heteroatom selected from N, O, and S;
- each Z7 independently is —C(O)-T2-T3- or —N(R′)-T2-T3- with T3 connected to R6, in which R′ is H or C1-6 alkyl, T2 is selected from alkylthioaryl, arylthioalkyl, alkylthioalkyl, arylthioaryl, alkyldithioaryl, aryldithioalkyl, alkyldithioalkyl and aryldithioaryl, and T3 is a covalent bond, —C(O)N(R″)—C1-8 alkyl, —N(R″)C(O)—C1-8 alkyl, or C1-8 alkyl, in which R″ is H or C1-6 alkyl;
- each of a and b independently is an integer between 1 and 6 inclusive;
- each of n, n1, n2, n3, n4, n5, and n6 is the molar fraction of the corresponding polyacetal unit ranging between 0 and 1;
- n+n1+n2+n3+n4+n5+n6=1;
- provided that neither n nor n6 is 0;
- R1 is a targeting group for a selected tissue, pathogen, cell, or cellular location;
- R2 is a charge group optionally substituted with one or more substituents selected from the group consisting of -Q-R1, -Q-R3, -Q-R4, and -Q-R5;
- R3 is a charge-modifying group;
- R4 is a hydrophobic group;
- R5 is a protective group;
- R6 is a polynucleotide;
- the ratio (m1) of the number of R1 to the total number of polyacetal units of the polyacetal is 0 to 0.25;
- the ratio (m3) of the number of R3 to the total number of polyacetal units of the polyacetal is 0 to 100;
- the ratio (m4) of the number of R4 to the total number of polyacetal units of the polyacetal is 0 to 30;
- the ratio (m5) of the number of R5 to the total number of polyacetal units of the polyacetal is 0 to 0.03;
- the ratio (m6) of the number of R6 to the total number of polyacetal units of the polyacetal is 0.0004 to 0.10;
- and
- the polyacetal backbone has a molecular weight of about 10 kDa to about 250 kDa.
Dependencies are inferred from the claim text.